What You Should Know:
– Citizen Health, an innovative AI-powered consumer health platform designed to support over 400 million individuals managing rare and complex conditions, has announced the successful closing of a $14.5 million seed round.
– The…
Continue Reading
Environmental factors amplified by climate change contribute significantly to the global burden of disease, disproportionately impacting vulnerable populations, such as individuals with rare diseases. Researchers require innovative, dynamic data linkage methods to enable the…
Continue Reading
The digital revolution in healthcare, amplified by the COVID-19 pandemic and artificial intelligence (AI) advances, has led to a surge in the development of digital technologies. However, integrating digital health solutions, especially AI-based ones,…
Continue Reading
Precision medicine is revolutionizing healthcare – by optimizing the efficiency and therapeutic benefit for particular groups of patients, especially by using genetic or molecular profiling. This approach enables a range of health disciplines, including…
Continue Reading
Ada Health, developer of an AI-powered symptom assessment and care navigation platform, expanded its leadership team as the company hit profitability and reported a 260% rise in revenue year over year.Nick Altebrando is the…
Continue Reading
TeleRare Health announced its launch to offer virtual care appointments for individuals with rare diseases, focusing on diagnosis, disease assessment and ongoing care. The platform connects patients with expert clinicians and offers molecular diagnostics as…
Continue Reading
The GEN-O application has proven its ability to revolution patient care and the genomic medicine landscape in the North West of England.Originally developed by Manchester University NHS Foundation Trust (MFT), GEN-O is reshaping virtual…
Continue Reading
What You Should Know:
– Researchers at Mass General Brigham have developed two powerful AI models, UNI and CONCH, that represent a significant leap forward in computational pathology (CPath).
– Published today in Nature Medicine, the…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
Indian AI drug discovery firm gets $1M to focus on rare diseasesPeptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven…
